Literature DB >> 603310

Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.

Z Amit, Z W Brown, D E Levitan, S O Ogren.   

Abstract

Ethanol-drinking rats were injected with the dopamine-beta-hydroxylase inhibitor FLA-57, prior to free-choice presentations of ethanol and water either for 5 alternate days (25 or 40 mg/kg i.p.) or for 5 consecutive days (45 mg/kg i.p.). In all cases, the FLA-57 treated animals markedly attenuated ethanol consumption while vehicle-injected controls showed no change from baseline. In the post-injection period ethanol intake gradually returned to baseline levels. Biochemical assays revealed that whole brain norepinephrine levels following injection of FLA-57 (15-60 mg/kg i.p.) were significantly depressed while dopamine and serotonin levels were slightly increased. It is suggested that norepinephrine may be involved in the mediation of the positive reinforcing properties of ethanol regulating its self-administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 603310

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  23 in total

1.  Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats.

Authors:  Nicholas W Gilpin; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

2.  Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.

Authors:  George A Kenna; Carolina L Haass-Koffler; William H Zywiak; Steven M Edwards; Michael B Brickley; Robert M Swift; Lorenzo Leggio
Journal:  Addict Biol       Date:  2015-06-02       Impact factor: 4.280

3.  Ethanol-associated behaviors of mice lacking norepinephrine.

Authors:  D Weinshenker; N C Rust; N S Miller; R D Palmiter
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 4.  Impact of gender on corticotropin-releasing factor and noradrenergic sensitivity in cocaine use disorder.

Authors:  Aimee L McRae-Clark; Angie M Cason; Amy S Kohtz; Megan Moran Santa-Maria; Gary Aston-Jones; Kathleen T Brady
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 5.  Noradrenergic targets for the treatment of alcohol use disorder.

Authors:  Carolina L Haass-Koffler; Robert M Swift; Lorenzo Leggio
Journal:  Psychopharmacology (Berl)       Date:  2018-02-20       Impact factor: 4.530

6.  Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.

Authors:  K Kiianmaa; L M Attila
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

7.  alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.

Authors:  Brendan M Walker; Dennis D Rasmussen; Murray A Raskind; George F Koob
Journal:  Alcohol       Date:  2008-03       Impact factor: 2.405

8.  The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.

Authors:  Dennis D Rasmussen; Laura Alexander; Julia Malone; David Federoff; Janice C Froehlich
Journal:  Alcohol       Date:  2014-07-14       Impact factor: 2.405

Review 9.  Norepinephrine at the nexus of arousal, motivation and relapse.

Authors:  Rodrigo A España; Brooke E Schmeichel; Craig W Berridge
Journal:  Brain Res       Date:  2016-01-07       Impact factor: 3.252

10.  Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects.

Authors:  H Anisman; M Ritch; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.